Skip to main content
Clinical Trials/CTRI/2023/05/052473
CTRI/2023/05/052473Not yet recruitingPhase 2

A Randomized Open-Labelled Controlled Clinical Study To Evaluate The Efficacy Of Langhana In The Management Of Amavata With Special Reference To Rheumatoid Arthritis.

Dr Surabhi G B0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1.Subjects of either gender in the age group of 21 to 60 years. 2.Subjects fulfilling the diagnostic criteria. 3.Subjects willing to give participate with written consent, which is conveyed in the language which the subject can understand. 4.Disease Activity Score 28 (DAS28) < 5.1

Exclusion Criteria

  • 1.Subjects who are taking medications for Rheumatoid Arthritis.
  • 2.Pregnant and lactating mothers.
  • 3.Subjects with uncontrolled systemic illness like Diabetes mellitus Type 1 & 2, Hypertension and associated with any other systemic diseases or complication.

Investigators

Sponsor
Dr Surabhi G B

Similar Trials